Heron Therapeutics, Inc. /De/

Ownership Transactions Reported by 18 Insiders

Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
4242 Campus Point Court, Suite 200, San Diego, CA

There are no Buy or Sell transactions made by insiders since 12/24/2023

Heron Therapeutics, Inc. /De/ executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Rubric Capital Management LP 10%+ Owner $57.4M Jul 21, 2023
Adam Morgan Director $15.3M Jan 19, 2024
Velan Capital Investment Management LP Other* $9.68M Jan 30, 2023
Craig Collard Chief Executive Officer, Director $3.6M Oct 19, 2024
Barry D. Quart Chief Executive Officer, Director $2.14M Jan 18, 2023
Kevin Kotler Director $1.24M Feb 22, 2023
Ira Duarte EVP, Chief Financial Officer $1.08M Oct 19, 2024
William P. Forbes EVP, Chief Development Officer $1.07M Oct 19, 2024
Michael Kaseta Director $505K Nov 4, 2024
Sharmila Dissanaike Director $298K Jan 19, 2024
Susan Rodriguez Director $298K Jan 19, 2024
Waage Christian Director $291K Jan 19, 2024
Craig Johnson Director $290K Jan 19, 2024
Stephen Davis Director $249K Dec 16, 2022
Lisa Peraza VP, Chief Accounting Officer $208K Jan 19, 2024
John Poyhonen President & CCO $160K Apr 13, 2023
David Leslie Szekeres EVP, Chief Operating Officer $123K Jul 13, 2023
Kimberly Manhard EVP, Drug Development $121K Apr 13, 2023

Recent Insider Transactions by Companies or Individuals for Heron Therapeutics, Inc. /De/

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.